» Articles » PMID: 27778099

Brain Structural Profile of Multiple System Atrophy Patients with Cognitive Impairment

Abstract

Current consensus diagnostic criteria for multiple system atrophy (MSA) consider dementia a non-supporting feature, although cognitive impairment and even frank dementia are reported in clinical practice. Mini-Mental State Examination (MMSE) is a commonly used global cognitive scale, and in a previous study, we established an MSA-specific screening cut-off score <27 to identify cognitive impairment. Finally, MSA neuroimaging findings suggest the presence of structural alterations in patients with cognitive deficits, although the extent of the anatomical changes is unclear. The aim of our multicenter study is to better characterize anatomical changes associated with cognitive impairment in MSA and to further investigate cortical and subcortical structural differences versus healthy controls (HC). We examined retrospectively 72 probable MSA patients [50 with normal cognition (MSA-NC) and 22 cognitively impaired (MSA-CI) based on MMSE <27] and compared them to 36 HC using gray- and white-matter voxel-based morphometry and fully automated subcortical segmentation. Compared to HC, MSA patients showed widespread cortical (bilateral frontal, occipito-temporal, and parietal areas), subcortical, and white-matter alterations. However, MSA-CI showed only focal volume reduction in the left dorsolateral prefrontal cortex compared with MSA-NC. These results suggest only a marginal contribution of cortical pathology to cognitive deficits. We believe that cognitive dysfunction is driven by focal fronto-striatal degeneration in line with the concept of "subcortical cognitive impairment".

Citing Articles

The Spectrum of Cognitive Impairment in Atypical Parkinsonism Syndromes: A Comprehensive Review of Current Understanding and Research.

Jellinger K Diseases. 2025; 13(2).

PMID: 39997046 PMC: 11854393. DOI: 10.3390/diseases13020039.


Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy.

Pasquini J, Sigurdsson H, Firbank M, Best L, Foster V, Galley D J Neurol. 2025; 272(3):195.

PMID: 39932591 PMC: 11814031. DOI: 10.1007/s00415-025-12932-5.


Mild cognitive impairment in multiple system atrophy: a brain network disorder.

Jellinger K J Neural Transm (Vienna). 2023; 130(10):1231-1240.

PMID: 37581647 DOI: 10.1007/s00702-023-02682-x.


Large-scale activation likelihood estimation meta-analysis of parkinsonian disorders.

Ellis E, Joutsa J, Morrison-Ham J, Younger E, Saward J, Caeyenberghs K Brain Commun. 2023; 5(3):fcad172.

PMID: 37324240 PMC: 10265724. DOI: 10.1093/braincomms/fcad172.


Multiple system atrophy - a clinicopathological update.

Jellinger K Free Neuropathol. 2023; 1.

PMID: 37283673 PMC: 10209915. DOI: 10.17879/freeneuropathology-2020-2813.


References
1.
Worker A, Blain C, Jarosz J, Chaudhuri K, Barker G, Williams S . Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. PLoS One. 2014; 9(11):e112638. PMC: 4236070. DOI: 10.1371/journal.pone.0112638. View

2.
Wenning G, Ben-Shlomo Y, Magalhaes M, Daniel S, Quinn N . Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995; 58(2):160-6. PMC: 1073311. DOI: 10.1136/jnnp.58.2.160. View

3.
Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G . Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord. 2011; 17(3):172-6. DOI: 10.1016/j.parkreldis.2010.12.010. View

4.
Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F . Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet. 2003; 361(9374):2046-8. DOI: 10.1016/s0140-6736(03)13616-1. View

5.
Minnerop M, Luders E, Specht K, Ruhlmann J, Schimke N, Thompson P . Callosal tissue loss in multiple system atrophy--a one-year follow-up study. Mov Disord. 2010; 25(15):2613-20. PMC: 2989455. DOI: 10.1002/mds.23318. View